Colorectal Cancer Molecular Diagnostics Industry Research Report 2023
Highlights
The global Colorectal Cancer Molecular Diagnostics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Colorectal Cancer Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Colorectal Cancer Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Colorectal Cancer Molecular Diagnostics include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent and Daangene, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Colorectal Cancer Molecular Diagnostics in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Polymerase Chain Reaction PCR, which accounted for % of the global market of Colorectal Cancer Molecular Diagnostics in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Molecular Diagnostics.
The Colorectal Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Colorectal Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Colorectal Cancer Molecular Diagnostics type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Colorectal Cancer Molecular Diagnostics are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Colorectal Cancer Molecular Diagnostics segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Colorectal Cancer Molecular Diagnostics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Colorectal Cancer Molecular Diagnostics market.
Colorectal Cancer Molecular Diagnostics Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Colorectal Cancer Molecular Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colorectal Cancer Molecular Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Colorectal Cancer Molecular Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Colorectal Cancer Molecular Diagnostics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colorectal Cancer Molecular Diagnostics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Colorectal Cancer Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The global Colorectal Cancer Molecular Diagnostics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Colorectal Cancer Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Colorectal Cancer Molecular Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Colorectal Cancer Molecular Diagnostics include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent and Daangene, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Colorectal Cancer Molecular Diagnostics in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Polymerase Chain Reaction PCR, which accounted for % of the global market of Colorectal Cancer Molecular Diagnostics in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Molecular Diagnostics.
The Colorectal Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Colorectal Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Roche Diagnostics
- Abbott
- Thermo Fisher
- Qiagen
- Illumina
- Biomerieux
- Bio-Rad
- Agilent
- Daangene
- Amoydx
Global markets are presented by Colorectal Cancer Molecular Diagnostics type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Colorectal Cancer Molecular Diagnostics are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Colorectal Cancer Molecular Diagnostics segment by Type
- Polymerase Chain Reaction PCR
- Molecular Hybridization
- Biochip
- Others
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Colorectal Cancer Molecular Diagnostics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Colorectal Cancer Molecular Diagnostics market.
Colorectal Cancer Molecular Diagnostics Segment by Application
- Hospital
- Third-Party Testing Agency
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Colorectal Cancer Molecular Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colorectal Cancer Molecular Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Colorectal Cancer Molecular Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Colorectal Cancer Molecular Diagnostics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colorectal Cancer Molecular Diagnostics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Colorectal Cancer Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Colorectal Cancer Molecular Diagnostics by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Polymerase Chain Reaction PCR
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Others
2.3 Colorectal Cancer Molecular Diagnostics by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Third-Party Testing Agency
2.3.4 Others
2.4 Assumptions and Limitations
3 COLORECTAL CANCER MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY TYPE
3.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Type (2018-2023)
3.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2023-2028)
4 COLORECTAL CANCER MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
4.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Application (2018-2023)
4.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Colorectal Cancer Molecular Diagnostics Market Perspective (2018-2029)
5.2 Global Colorectal Cancer Molecular Diagnostics Growth Trends by Region
5.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Colorectal Cancer Molecular Diagnostics Historic Market Size by Region (2018-2023)
5.2.3 Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029)
5.3 Colorectal Cancer Molecular Diagnostics Market Dynamics
5.3.1 Colorectal Cancer Molecular Diagnostics Industry Trends
5.3.2 Colorectal Cancer Molecular Diagnostics Market Drivers
5.3.3 Colorectal Cancer Molecular Diagnostics Market Challenges
5.3.4 Colorectal Cancer Molecular Diagnostics Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue
6.1.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue (2018-2023)
6.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2018-2023)
6.2 Global Colorectal Cancer Molecular Diagnostics Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Colorectal Cancer Molecular Diagnostics Head office and Area Served
6.4 Global Colorectal Cancer Molecular Diagnostics Players, Product Type & Application
6.5 Global Colorectal Cancer Molecular Diagnostics Players, Date of Enter into This Industry
6.6 Global Colorectal Cancer Molecular Diagnostics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
7.2 North America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
7.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
8.2 Europe Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
8.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
9.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
9.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
10.2 Latin America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
10.4 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
11.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
11.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Introduction
11.1.4 Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Colorectal Cancer Molecular Diagnostics Introduction
11.2.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.2.5 Abbott Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Detail
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Introduction
11.3.4 Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.3.5 Thermo Fisher Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Introduction
11.4.4 Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.4.5 Qiagen Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Colorectal Cancer Molecular Diagnostics Introduction
11.5.4 Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.5.5 Illumina Recent Development
11.6 Biomerieux
11.6.1 Biomerieux Company Detail
11.6.2 Biomerieux Business Overview
11.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Introduction
11.6.4 Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.6.5 Biomerieux Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Introduction
11.7.4 Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.7.5 Bio-Rad Recent Development
11.8 Agilent
11.8.1 Agilent Company Detail
11.8.2 Agilent Business Overview
11.8.3 Agilent Colorectal Cancer Molecular Diagnostics Introduction
11.8.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.8.5 Agilent Recent Development
11.9 Daangene
11.9.1 Daangene Company Detail
11.9.2 Daangene Business Overview
11.9.3 Daangene Colorectal Cancer Molecular Diagnostics Introduction
11.9.4 Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.9.5 Daangene Recent Development
11.10 Amoydx
11.10.1 Amoydx Company Detail
11.10.2 Amoydx Business Overview
11.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Introduction
11.10.4 Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.10.5 Amoydx Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Colorectal Cancer Molecular Diagnostics by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Polymerase Chain Reaction PCR
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Others
2.3 Colorectal Cancer Molecular Diagnostics by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Third-Party Testing Agency
2.3.4 Others
2.4 Assumptions and Limitations
3 COLORECTAL CANCER MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY TYPE
3.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Type (2018-2023)
3.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2023-2028)
4 COLORECTAL CANCER MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
4.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Application (2018-2023)
4.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Colorectal Cancer Molecular Diagnostics Market Perspective (2018-2029)
5.2 Global Colorectal Cancer Molecular Diagnostics Growth Trends by Region
5.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Colorectal Cancer Molecular Diagnostics Historic Market Size by Region (2018-2023)
5.2.3 Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029)
5.3 Colorectal Cancer Molecular Diagnostics Market Dynamics
5.3.1 Colorectal Cancer Molecular Diagnostics Industry Trends
5.3.2 Colorectal Cancer Molecular Diagnostics Market Drivers
5.3.3 Colorectal Cancer Molecular Diagnostics Market Challenges
5.3.4 Colorectal Cancer Molecular Diagnostics Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue
6.1.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue (2018-2023)
6.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2018-2023)
6.2 Global Colorectal Cancer Molecular Diagnostics Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Colorectal Cancer Molecular Diagnostics Head office and Area Served
6.4 Global Colorectal Cancer Molecular Diagnostics Players, Product Type & Application
6.5 Global Colorectal Cancer Molecular Diagnostics Players, Date of Enter into This Industry
6.6 Global Colorectal Cancer Molecular Diagnostics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
7.2 North America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
7.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
8.2 Europe Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
8.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
9.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
9.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
10.2 Latin America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
10.4 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2018-2029)
11.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023)
11.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Introduction
11.1.4 Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Colorectal Cancer Molecular Diagnostics Introduction
11.2.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.2.5 Abbott Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Detail
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Introduction
11.3.4 Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.3.5 Thermo Fisher Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Introduction
11.4.4 Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.4.5 Qiagen Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Colorectal Cancer Molecular Diagnostics Introduction
11.5.4 Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.5.5 Illumina Recent Development
11.6 Biomerieux
11.6.1 Biomerieux Company Detail
11.6.2 Biomerieux Business Overview
11.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Introduction
11.6.4 Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.6.5 Biomerieux Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Introduction
11.7.4 Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.7.5 Bio-Rad Recent Development
11.8 Agilent
11.8.1 Agilent Company Detail
11.8.2 Agilent Business Overview
11.8.3 Agilent Colorectal Cancer Molecular Diagnostics Introduction
11.8.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.8.5 Agilent Recent Development
11.9 Daangene
11.9.1 Daangene Company Detail
11.9.2 Daangene Business Overview
11.9.3 Daangene Colorectal Cancer Molecular Diagnostics Introduction
11.9.4 Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.9.5 Daangene Recent Development
11.10 Amoydx
11.10.1 Amoydx Company Detail
11.10.2 Amoydx Business Overview
11.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Introduction
11.10.4 Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022)
11.10.5 Amoydx Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Colorectal Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 7. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2024-2029)
Table 9. Global Colorectal Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2018-2023)
Table 11. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2024-2029)
Table 13. Global Colorectal Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Colorectal Cancer Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Colorectal Cancer Molecular Diagnostics Market Share by Region (2018-2023)
Table 16. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Colorectal Cancer Molecular Diagnostics Market Share by Region (2024-2029)
Table 18. Colorectal Cancer Molecular Diagnostics Market Trends
Table 19. Colorectal Cancer Molecular Diagnostics Market Drivers
Table 20. Colorectal Cancer Molecular Diagnostics Market Challenges
Table 21. Colorectal Cancer Molecular Diagnostics Market Restraints
Table 22. Global Top Colorectal Cancer Molecular Diagnostics Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Colorectal Cancer Molecular Diagnostics Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Colorectal Cancer Molecular Diagnostics, Headquarters and Area Served
Table 26. Global Colorectal Cancer Molecular Diagnostics Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Colorectal Cancer Molecular Diagnostics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Roche Diagnostics Company Detail
Table 46. Roche Diagnostics Business Overview
Table 47. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product
Table 48. Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 49. Roche Diagnostics Recent Development
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott Colorectal Cancer Molecular Diagnostics Product
Table 53. Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Thermo Fisher Company Detail
Table 56. Thermo Fisher Business Overview
Table 57. Thermo Fisher Colorectal Cancer Molecular Diagnostics Product
Table 58. Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 59. Thermo Fisher Recent Development
Table 60. Qiagen Company Detail
Table 61. Qiagen Business Overview
Table 62. Qiagen Colorectal Cancer Molecular Diagnostics Product
Table 63. Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 64. Qiagen Recent Development
Table 65. Illumina Company Detail
Table 66. Illumina Business Overview
Table 67. Illumina Colorectal Cancer Molecular Diagnostics Product
Table 68. Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 69. Illumina Recent Development
Table 70. Biomerieux Company Detail
Table 71. Biomerieux Business Overview
Table 72. Biomerieux Colorectal Cancer Molecular Diagnostics Product
Table 73. Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 74. Biomerieux Recent Development
Table 75. Bio-Rad Company Detail
Table 76. Bio-Rad Business Overview
Table 77. Bio-Rad Colorectal Cancer Molecular Diagnostics Product
Table 78. Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 79. Bio-Rad Recent Development
Table 80. Agilent Company Detail
Table 81. Agilent Business Overview
Table 82. Agilent Colorectal Cancer Molecular Diagnostics Product
Table 83. Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 84. Agilent Recent Development
Table 85. Daangene Company Detail
Table 86. Daangene Business Overview
Table 87. Daangene Colorectal Cancer Molecular Diagnostics Product
Table 88. Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 89. Daangene Recent Development
Table 90. Amoydx Company Detail
Table 91. Amoydx Business Overview
Table 92. Amoydx Colorectal Cancer Molecular Diagnostics Product
Table 93. Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 94. Amoydx Recent Development
Table 95. Roche Diagnostics Company Information
Table 96. Roche Diagnostics Business Overview
Table 97. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 98. Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 99. Roche Diagnostics Recent Development
Table 100. Abbott Company Information
Table 101. Abbott Business Overview
Table 102. Abbott Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 103. Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 104. Abbott Recent Development
Table 105. Thermo Fisher Company Information
Table 106. Thermo Fisher Business Overview
Table 107. Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 108. Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 109. Thermo Fisher Recent Development
Table 110. Qiagen Company Information
Table 111. Qiagen Business Overview
Table 112. Qiagen Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 113. Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 114. Qiagen Recent Development
Table 115. Illumina Company Information
Table 116. Illumina Business Overview
Table 117. Illumina Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 118. Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 119. Illumina Recent Development
Table 120. Biomerieux Company Information
Table 121. Biomerieux Business Overview
Table 122. Biomerieux Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 123. Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 124. Biomerieux Recent Development
Table 125. Bio-Rad Company Information
Table 126. Bio-Rad Business Overview
Table 127. Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 128. Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 129. Bio-Rad Recent Development
Table 130. Agilent Company Information
Table 131. Agilent Business Overview
Table 132. Agilent Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 133. Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 134. Agilent Recent Development
Table 135. Daangene Company Information
Table 136. Daangene Business Overview
Table 137. Daangene Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 139. Daangene Recent Development
Table 140. Amoydx Company Information
Table 141. Amoydx Business Overview
Table 142. Amoydx Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 143. Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Colorectal Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 7. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2024-2029)
Table 9. Global Colorectal Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2018-2023)
Table 11. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2024-2029)
Table 13. Global Colorectal Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Colorectal Cancer Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Colorectal Cancer Molecular Diagnostics Market Share by Region (2018-2023)
Table 16. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Colorectal Cancer Molecular Diagnostics Market Share by Region (2024-2029)
Table 18. Colorectal Cancer Molecular Diagnostics Market Trends
Table 19. Colorectal Cancer Molecular Diagnostics Market Drivers
Table 20. Colorectal Cancer Molecular Diagnostics Market Challenges
Table 21. Colorectal Cancer Molecular Diagnostics Market Restraints
Table 22. Global Top Colorectal Cancer Molecular Diagnostics Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Colorectal Cancer Molecular Diagnostics Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Colorectal Cancer Molecular Diagnostics, Headquarters and Area Served
Table 26. Global Colorectal Cancer Molecular Diagnostics Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Colorectal Cancer Molecular Diagnostics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Roche Diagnostics Company Detail
Table 46. Roche Diagnostics Business Overview
Table 47. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product
Table 48. Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 49. Roche Diagnostics Recent Development
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott Colorectal Cancer Molecular Diagnostics Product
Table 53. Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Thermo Fisher Company Detail
Table 56. Thermo Fisher Business Overview
Table 57. Thermo Fisher Colorectal Cancer Molecular Diagnostics Product
Table 58. Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 59. Thermo Fisher Recent Development
Table 60. Qiagen Company Detail
Table 61. Qiagen Business Overview
Table 62. Qiagen Colorectal Cancer Molecular Diagnostics Product
Table 63. Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 64. Qiagen Recent Development
Table 65. Illumina Company Detail
Table 66. Illumina Business Overview
Table 67. Illumina Colorectal Cancer Molecular Diagnostics Product
Table 68. Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 69. Illumina Recent Development
Table 70. Biomerieux Company Detail
Table 71. Biomerieux Business Overview
Table 72. Biomerieux Colorectal Cancer Molecular Diagnostics Product
Table 73. Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 74. Biomerieux Recent Development
Table 75. Bio-Rad Company Detail
Table 76. Bio-Rad Business Overview
Table 77. Bio-Rad Colorectal Cancer Molecular Diagnostics Product
Table 78. Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 79. Bio-Rad Recent Development
Table 80. Agilent Company Detail
Table 81. Agilent Business Overview
Table 82. Agilent Colorectal Cancer Molecular Diagnostics Product
Table 83. Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 84. Agilent Recent Development
Table 85. Daangene Company Detail
Table 86. Daangene Business Overview
Table 87. Daangene Colorectal Cancer Molecular Diagnostics Product
Table 88. Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 89. Daangene Recent Development
Table 90. Amoydx Company Detail
Table 91. Amoydx Business Overview
Table 92. Amoydx Colorectal Cancer Molecular Diagnostics Product
Table 93. Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 94. Amoydx Recent Development
Table 95. Roche Diagnostics Company Information
Table 96. Roche Diagnostics Business Overview
Table 97. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 98. Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 99. Roche Diagnostics Recent Development
Table 100. Abbott Company Information
Table 101. Abbott Business Overview
Table 102. Abbott Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 103. Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 104. Abbott Recent Development
Table 105. Thermo Fisher Company Information
Table 106. Thermo Fisher Business Overview
Table 107. Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 108. Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 109. Thermo Fisher Recent Development
Table 110. Qiagen Company Information
Table 111. Qiagen Business Overview
Table 112. Qiagen Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 113. Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 114. Qiagen Recent Development
Table 115. Illumina Company Information
Table 116. Illumina Business Overview
Table 117. Illumina Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 118. Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 119. Illumina Recent Development
Table 120. Biomerieux Company Information
Table 121. Biomerieux Business Overview
Table 122. Biomerieux Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 123. Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 124. Biomerieux Recent Development
Table 125. Bio-Rad Company Information
Table 126. Bio-Rad Business Overview
Table 127. Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 128. Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 129. Bio-Rad Recent Development
Table 130. Agilent Company Information
Table 131. Agilent Business Overview
Table 132. Agilent Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 133. Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 134. Agilent Recent Development
Table 135. Daangene Company Information
Table 136. Daangene Business Overview
Table 137. Daangene Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
Table 139. Daangene Recent Development
Table 140. Amoydx Company Information
Table 141. Amoydx Business Overview
Table 142. Amoydx Colorectal Cancer Molecular Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 143. Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million) Portfolio
